| Year |
Citation |
Score |
| 2024 |
Chhabra S, Jerkins JH, Monahan K, Szabo A, Shah NN, Abedin S, Runaas L, Fenske TS, Pasquini MC, Shaw BE, Drobyski WR, Saber W, D'Souza A, Dhakal B, Mohan M, et al. Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 38177221 DOI: 10.1038/s41409-023-02178-y |
0.346 |
|
| 2023 |
Yuan C, Rayasam A, Moe A, Hayward M, Wells C, Szabo A, Mackenzie A, Salzman N, Drobyski WR. Interleukin-9 production by type 2 innate lymphoid cells induces Paneth cell metaplasia and small intestinal remodeling. Nature Communications. 14: 7963. PMID 38042840 DOI: 10.1038/s41467-023-43248-5 |
0.346 |
|
| 2023 |
Moe A, Rayasam A, Sauber G, Shah RK, Yuan CY, Szabo A, Moore BM, Colonna M, Cui W, Romero J, Zamora AE, Hillard CJ, Drobyski WR. MICROGLIAL CELL EXPRESSION OF THE TYPE 2 CANNABINOID RECEPTOR REGULATES IMMUNE-MEDIATED NEUROINFLAMMATION. Biorxiv : the Preprint Server For Biology. PMID 37645843 DOI: 10.1101/2023.08.10.552854 |
0.436 |
|
| 2022 |
Piper C, Hainstock E, Yin-Yuan C, Chen Y, Khatun A, Kasmani M, Evans J, Miller JA, Gorski J, Cui W, Drobyski WR. Single cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T cell lineage that induces GI tract GVHD. Blood Advances. PMID 35015822 DOI: 10.1182/bloodadvances.2021006084 |
0.522 |
|
| 2021 |
Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, et al. Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. Transplantation and Cellular Therapy. 28: 717. PMID 36202527 DOI: 10.1016/j.jtct.2021.01.005 |
0.413 |
|
| 2021 |
Rayasam A, Drobyski WR. Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Host Disease. Frontiers in Immunology. 12: 779076. PMID 34899738 DOI: 10.3389/fimmu.2021.779076 |
0.432 |
|
| 2021 |
Ciecko AE, Schauder DM, Foda B, Petrova G, Kasmani MY, Burns R, Lin CW, Drobyski WR, Cui W, Chen YG. Self-Renewing Islet TCF1 CD8 T Cells Undergo IL-27-Controlled Differentiation to Become TCF1 Terminal Effectors during the Progression of Type 1 Diabetes. Journal of Immunology (Baltimore, Md. : 1950). PMID 34507949 DOI: 10.4049/jimmunol.2100362 |
0.505 |
|
| 2021 |
Dhakal B, Thapa B, Dong H, Tarima S, Chhabra S, D'Souza A, Drobyski W, Abid M, Shah N, Fenske T, Longo W, Hari P, Hamadani M. Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Clinical Lymphoma, Myeloma & Leukemia. PMID 34257042 DOI: 10.1016/j.clml.2021.06.004 |
0.35 |
|
| 2021 |
Letscher H, Agbogan VA, Korniotis S, Gastineau P, Tejerina E, Gras C, Mégret J, Moe A, Drobyski WR, Zavala F. Toll-like receptor-9 stimulated plasmacytoid dendritic cell precursors suppress autoimmune neuroinflammation in a murine model of multiple sclerosis. Scientific Reports. 11: 4735. PMID 33637789 DOI: 10.1038/s41598-021-84023-0 |
0.346 |
|
| 2020 |
Yuan CY, Zhou V, Sauber G, Stollenwerk TM, Komorowski R, López A, Tolon RM, Romero J, Hillard CJ, Drobyski WR. Signaling Through the Type 2 Cannabinoid Receptor Regulates the Severity of Acute and Chronic Graft versus Host Disease. Blood. PMID 33027805 DOI: 10.1182/blood.2020004871 |
0.517 |
|
| 2020 |
Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, et al. Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32653622 DOI: 10.1016/J.Bbmt.2020.07.005 |
0.329 |
|
| 2020 |
Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Pasquini MC, Rizzo RD, Saber W, Shah NN, et al. Fludarabine/busulfan conditioning based allogeneic hematopoietic cell transplantation for myelofibrosis: Role of ruxolitinib in improving survival outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31982543 DOI: 10.1016/J.Bbmt.2020.01.010 |
0.324 |
|
| 2019 |
Piper C, Zhou V, Komorowski R, Szabo A, Vincent B, Serody J, Alegre ML, Edelson BT, Taneja R, Drobyski WR. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T Cells Promote Indirect Alloantigen Presentation in the GI Tract during GVHD. Blood. PMID 31880771 DOI: 10.1182/Blood.2019001696 |
0.497 |
|
| 2019 |
Badar T, Khan MA, Szabo A, Drobyski W, Chhabra S, Dhakal B, Fenske TS, Hamadani M, Hari P, Jerkins JH, Shah NN, Shaw BE, D'Souza A. Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-6. PMID 31347424 DOI: 10.1080/13506129.2019.1645001 |
0.408 |
|
| 2019 |
Abedin S, McKenna E, Chhabra S, Pasquini M, Shah NN, Jerkins J, Baim A, Runaas L, Longo W, Drobyski W, Hari PN, Hamadani M. Efficacy, toxicity and infectious Complications in Ruxolitinib Treated Patients with Corticosteroid-refractory Graft-versus-host Disease after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30965140 DOI: 10.1016/J.Bbmt.2019.04.003 |
0.381 |
|
| 2019 |
Piper C, Drobyski WR. Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease. Frontiers in Immunology. 10: 163. PMID 30853956 DOI: 10.3389/fimmu.2019.00163 |
0.432 |
|
| 2018 |
Murthy GSG, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, et al. OUTCOMES OF REDUCED INTENSITY CONDITIONING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION PERFORMED IN THE INPATIENT VERSUS OUTPATIENT SETTING. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30572109 DOI: 10.1016/J.Bbmt.2018.12.069 |
0.318 |
|
| 2018 |
Xin G, Zander R, Schauder DM, Chen Y, Weinstein JS, Drobyski WR, Tarakanova V, Craft J, Cui W. Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection. Nature Communications. 9: 5037. PMID 30487586 DOI: 10.1038/S41467-018-07492-4 |
0.397 |
|
| 2018 |
Agle K, Vincent BG, Piper C, Belle L, Zhou V, Shlomchik W, Serody JS, Drobyski WR. Bim regulates the survival and suppressive capability of CD8 FOXP3 regulatory T cells during murine GVHD. Blood. PMID 29769260 DOI: 10.1182/Blood-2017-09-807156 |
0.476 |
|
| 2018 |
Jeschke JC, Mayne CG, Ziegelbauer J, DeCiantis CL, Singh S, Kumar SN, Suchi M, Iwakura Y, Drobyski WR, Salzman NH, Williams CB. A model of TH17-associated ileal hyperplasia that requires both IL-17A and IFNγ to generate self-tolerance and prevent colitis. Mucosal Immunology. PMID 29728642 DOI: 10.1038/s41385-018-0023-6 |
0.409 |
|
| 2018 |
Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, et al. Peripheral Blood Grafts for T-Cell Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29680516 DOI: 10.1016/J.Bbmt.2018.04.010 |
0.436 |
|
| 2018 |
Badar T, Hari P, Chhabra S, Dhakal B, Drobyski WR, Fenske TS, Hamadani M, Pasquini M, Saber W, Shah NN, Shaw BE, D'Souza A. Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective. Bone Marrow Transplantation. PMID 29679076 DOI: 10.1038/s41409-018-0178-5 |
0.309 |
|
| 2018 |
Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, et al. Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft versus host disease: low incidence of lower gastrointestinal tract disease. Haematologica. PMID 29351985 DOI: 10.3324/Haematol.2017.183434 |
0.392 |
|
| 2017 |
Belle L, Zhou V, Stuhr KL, Beatka M, Siebers EM, Knight JM, Lawlor MW, Weaver C, Hashizume M, Hillard CJ, Drobyski WR. Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD. Jci Insight. 2. PMID 28724796 DOI: 10.1172/Jci.Insight.93726 |
0.439 |
|
| 2017 |
Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, et al. Recipient Immune-Modulation with Atorvastatin for Acute Graft-Versus-Host Disease Prophylaxis Following Allogeneic Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28412518 DOI: 10.1016/J.Bbmt.2017.04.009 |
0.373 |
|
| 2017 |
Drobyski W, Szabo A, Hari P, Hamadani M, Herbert K, Keever-Taylor C, D'Souza A, Eapen M, Fenske TS, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw BE, Yim S, et al. Results of a Phase II Clinical Trial of Tocilizumab, Tacrolimus and Methotrexate (Toc/Tac/MTX) for the Prevention of Acute Graft Versus Host Disease (GVHD) and Matched Case Control Comparison to Tac/MTX after Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 23: 1. DOI: 10.1016/J.Bbmt.2016.12.647 |
0.454 |
|
| 2016 |
Dodge J, Stephans A, Lai J, Drobyski WR, Chen X. Effects of Donor Vitamin a Deficiency and Pharmacological Modulation of Donor T Cell Retinoic Acid Pathway on the Severity of Experimental Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27596131 DOI: 10.1016/j.bbmt.2016.09.001 |
0.481 |
|
| 2016 |
Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M. Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. Bone Marrow Transplantation. PMID 27595288 DOI: 10.1038/Bmt.2016.216 |
0.434 |
|
| 2016 |
Zhou V, Agle K, Chen X, Beres A, Komorowski R, Belle L, Taylor C, Zhu F, Haribhai D, Williams CB, Verbsky J, Blumenschein W, Sadekova S, Bowman E, Ballantyne C, ... ... Drobyski WR, et al. A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease. The Journal of Clinical Investigation. PMID 27500496 DOI: 10.1172/Jci80874 |
0.785 |
|
| 2016 |
Belle L, Agle K, Zhou V, Yin-Yuan C, Komorowski R, Eastwood D, Logan B, Sun J, Ghilardi N, Cua D, Williams CB, Gaignage M, Marillier R, van Snick J, Drobyski WR. Blockade of interleukin 27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing FOXP3 expression. Blood. PMID 27488350 DOI: 10.1182/Blood-2016-02-698241 |
0.468 |
|
| 2016 |
Epperla N, Pasquini M, Pierce K, Drobyski WR, Rizzo JD, Horowitz MM, Saber W, Zellner K, Ramirez S, Bartz K, Raj RV, Hari PN, Hamadani M. Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft. Bone Marrow Transplantation. PMID 27479688 DOI: 10.1038/bmt.2016.200 |
0.399 |
|
| 2016 |
Lazaryan A, Wang T, Spellman SR, Wang HL, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, ... ... Drobyski W, et al. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: A report from the Center for International Blood and Marrow Transplant Research. Haematologica. PMID 27247320 DOI: 10.3324/Haematol.2016.143271 |
0.396 |
|
| 2016 |
Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival. Clinical Lymphoma, Myeloma & Leukemia. PMID 27160644 DOI: 10.1016/j.clml.2016.03.001 |
0.341 |
|
| 2016 |
Dhakal B, D'Souza A, Pasquini M, Saber W, Fenske TS, Moss RB, Drobyski WR, Hari P, Abidi MZ. DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation. Case Reports in Medicine. 2016: 8503275. PMID 26941799 DOI: 10.1155/2016/8503275 |
0.315 |
|
| 2016 |
Ganetsky A, Frey NV, Loren AW, Hexner EO, Mangan JK, Gill SI, Luger S, Cohen AD, Babushok DV, Stadtmauer EA, Smith J, Drobyski WR, Kraus SK, Timlin C, Porter DL. Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract Blood. 128: 2245-2245. DOI: 10.1182/Blood.V128.22.2245.2245 |
0.32 |
|
| 2016 |
Belle L, Koester E, Hansen E, Lawlor M, Hillard C, Drobyski WR. Host Interleukin 6 and Indoleamine 2,3 Dioxygenase Regulate Inflammation in the Brain during Graft Versus Host Disease Blood. 128: 2145-2145. DOI: 10.1182/Blood.V128.22.2145.2145 |
0.477 |
|
| 2016 |
Hamadani M, Pasquini MC, Visotcky A, Ahn KW, Horowitz MM, Boyd J, Rizzo JD, Saber W, Drobyski W, Arce-lara C, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, et al. Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT) Biology of Blood and Marrow Transplantation. 22. DOI: 10.1016/J.Bbmt.2015.11.332 |
0.483 |
|
| 2015 |
Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, ... ... Drobyski WR, et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 266-74. PMID 25445023 DOI: 10.1016/J.Bbmt.2014.10.021 |
0.333 |
|
| 2015 |
Dhakal B, Martens M, Kapke J, D'Souza A, Pasquini MC, Saber W, Hamadani M, Drobyski W, Rizzo JD, Horowitz MM, Zhang M, Hari PN. Outcomes of Allogeneic Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): Impact of Disease Risk and Conditioning Regimen Biology of Blood and Marrow Transplantation. 21. DOI: 10.1016/J.Bbmt.2014.11.441 |
0.431 |
|
| 2014 |
Dhakal B, Strouse C, D'Souza A, Arce-Lara C, Esselman J, Eastwood D, Pasquini M, Saber W, Drobyski W, Rizzo JD, Hari PN, Hamadani M. Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1926-31. PMID 25111581 DOI: 10.1016/J.Bbmt.2014.08.002 |
0.313 |
|
| 2014 |
Agle K, Zhou V, Chen X, Beres A, Komorowski R, Taylor C, Haribhai D, Williams C, Verbsky J, Blumenschein W, Sadekova S, Bowman E, Weaver C, Cua D, Drobyski WR. Coordinate Expression of Beta 2 Integrins and the Interleukin 23 Receptor Define a Pathogenic CD4+ T Cell Population That Induces Colonic Inflammation during Graft Versus Host Disease Blood. 124: 537-537. DOI: 10.1182/Blood.V124.21.537.537 |
0.773 |
|
| 2014 |
Kroll TM, Singavi A, Schmidt W, Eastwood D, Drobyski W, Horowitz MM, Palmer J, Pasquini MC, Rizzo JD, Saber W, Hari PN, Fenske T. Safety of Outpatient Autologous Hematopoietic Cell Transplantation (AuHCT) for Multiple Myeloma and Lymphoma Biology of Blood and Marrow Transplantation. 20. DOI: 10.1016/J.Bbmt.2013.12.166 |
0.494 |
|
| 2013 |
Beres AJ, Drobyski WR. The role of regulatory T cells in the biology of graft versus host disease. Frontiers in Immunology. 4: 163. PMID 23805140 DOI: 10.3389/Fimmu.2013.00163 |
0.781 |
|
| 2013 |
Chen X, Dodge J, Komorowski R, Drobyski WR. A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease. Blood. 121: 3970-80. PMID 23529927 DOI: 10.1182/blood-2012-08-445130 |
0.45 |
|
| 2013 |
Michaelis LC, Saad A, Zhong X, Le-Rademacher J, Freytes CO, Marks DI, Lazarus HM, Bird JM, Holmberg L, Kamble RT, Kumar S, Lill M, Meehan KR, Saber W, Schriber J, ... ... Drobyski W, et al. Salvage second hematopoietic cell transplantation in myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 760-6. PMID 23298856 DOI: 10.1016/J.Bbmt.2013.01.004 |
0.407 |
|
| 2013 |
Cornell RF, Drobyski W, Zhong X, Thompson J, Horowitz MM, Fenske T, Palmer J, Pasquini MC, Saber W, Thomas M, Randhawa JK, Zhang M, Hari PN. Risk Factors and Clinical Features of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation (AHCT) Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.064 |
0.399 |
|
| 2012 |
Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB, Drobyski WR. CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. Journal of Immunology (Baltimore, Md. : 1950). 189: 464-74. PMID 22649199 DOI: 10.4049/Jimmunol.1200886 |
0.786 |
|
| 2012 |
Rangarajan H, Yassai M, Subramanian H, Komorowski R, Whitaker M, Gorski J, Drobyski WR. Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease. Blood. 119: 6354-64. PMID 22496151 DOI: 10.1182/blood-2012-01-401596 |
0.467 |
|
| 2012 |
Battiwalla M, Ellis K, Li P, Pavletic SZ, Akpek G, Hematti P, Klumpp TR, Maziarz RT, Savani BN, Aljurf MD, Cairo MS, Drobyski WR, George B, Hahn T, Khera N, et al. HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1302-8. PMID 22414493 DOI: 10.1016/J.Bbmt.2012.02.011 |
0.386 |
|
| 2012 |
Weisdorf D, Cooley S, Devine S, Fehniger TA, DiPersio J, Anasetti C, Waller EK, Porter D, Farag S, Drobyski W, Defor T, Haagenson M, Curtsinger J, Miller J. T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 937-43. PMID 22155505 DOI: 10.1016/J.Bbmt.2011.11.024 |
0.498 |
|
| 2011 |
Beres A, Komorowski R, Mihara M, Drobyski WR. Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3969-83. PMID 21558402 DOI: 10.1158/1078-0432.Ccr-10-3347 |
0.783 |
|
| 2011 |
Cogbill CH, Drobyski WR, Komorowski RA. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 24: 117-25. PMID 20953169 DOI: 10.1038/modpathol.2010.163 |
0.394 |
|
| 2011 |
Beres A, Haribhai D, Tessler-Verville C, Gonyo P, Hessner M, Williams C, Drobyski WR. Induction of a Novel Population of CD8+ Foxp3+ Regulatory T Cells During Graft Versus Host Disease Blood. 118: 821-821. DOI: 10.1182/Blood.V118.21.821.821 |
0.776 |
|
| 2010 |
Das R, Komorowski R, Hessner MJ, Subramanian H, Huettner CS, Cua D, Drobyski WR. Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses. Blood. 115: 5249-58. PMID 20382845 DOI: 10.1182/Blood-2009-11-255422 |
0.457 |
|
| 2010 |
Chen X, Das R, Komorowski R, van Snick J, Uyttenhove C, Drobyski WR. Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 123-8. PMID 19772944 DOI: 10.1016/J.Bbmt.2009.09.008 |
0.451 |
|
| 2009 |
Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N. Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease Biology of Blood and Marrow Transplantation. 15: 1609-1619. PMID 19744572 DOI: 10.1016/J.Bbmt.2009.08.020 |
0.562 |
|
| 2009 |
Chen X, Das R, Komorowski R, Beres A, Hessner MJ, Mihara M, Drobyski WR. Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood. 114: 891-900. PMID 19491393 DOI: 10.1182/Blood-2009-01-197178 |
0.775 |
|
| 2009 |
Das R, Chen X, Komorowski R, Hessner MJ, Drobyski WR. Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease. Blood. 113: 2352-62. PMID 19059877 DOI: 10.1182/Blood-2008-08-175448 |
0.414 |
|
| 2009 |
Das R, Drobyski W. Targeted Protection of the Colon in the Absence of Donor Antigen-Presenting Cell -Derived Interleukin 23 Allows for Separation of Graft Versus Host and Graft Versus Leukemia Effects Biology of Blood and Marrow Transplantation. 15: 12. DOI: 10.1016/J.Bbmt.2008.12.034 |
0.379 |
|
| 2008 |
Drobyski WR, Hari P, Keever-Taylor C, Komorowski R, Grossman W. Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplantation. 43: 169-77. PMID 18762759 DOI: 10.1038/bmt.2008.295 |
0.339 |
|
| 2008 |
Levine JE, Barrett AJ, Zhang MJ, Arora M, Pulsipher MA, Bunin N, Fort J, Loberiza F, Porter D, Giralt S, Drobyski W, Wang D, Pavletic S, Ringden O, Horowitz MM, et al. Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population. Bone Marrow Transplantation. 42: 201-5. PMID 18490913 DOI: 10.1038/Bmt.2008.135 |
0.395 |
|
| 2008 |
Chen X, Das R, Komorowski R, Mihara M, Drobyski W. Blockade of Interleukin 6 Signaling Attenuates Graft Versus Host Disease by Augmenting Regulatory T Cell Reconstitution Blood. 112: 811-811. DOI: 10.1182/Blood.V112.11.811.811 |
0.611 |
|
| 2008 |
Das R, Komorowski R, Ghilardi N, Hessner M, Drobyski W. 24: Critical Role for Donor Antigen-Presenting Cell Secretion of Interleukin 23 in the Pathophysiology of Graft Versus Host Disease of the Colon Biology of Blood and Marrow Transplantation. 14: 11-12. DOI: 10.1016/J.Bbmt.2007.12.032 |
0.421 |
|
| 2007 |
Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood. 110: 3804-13. PMID 17693581 DOI: 10.1182/blood-2007-05-091074 |
0.555 |
|
| 2007 |
Gorski J, Chen X, Gendelman M, Yassai M, Krueger A, Tivol E, Logan B, Komorowski R, Vodanovic-Jankovic S, Drobyski WR. Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. Blood. 109: 5502-10. PMID 17347406 DOI: 10.1182/Blood-2006-12-061713 |
0.523 |
|
| 2007 |
Chen X, Van Snick J, Uyttenhove C, Komorowski R, Drobyski WR. Inhibition of Interleukin 17 Significantly Attenuates the Severity of Autoimmune-Mediated Pathological Damage in Chronic Graft Versus Host Disease. Blood. 110: 70-70. DOI: 10.1182/blood.v110.11.70.70 |
0.503 |
|
| 2006 |
Vodanovic-Jankovic S, Drobyski WR. Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 1125-34. PMID 17085305 DOI: 10.1016/j.bbmt.2006.08.033 |
0.452 |
|
| 2006 |
Vodanovic-Jankovic S, Hari P, Jacobs P, Komorowski R, Drobyski WR. NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145. Blood. 107: 827-34. PMID 16174760 DOI: 10.1182/blood-2005-05-1820 |
0.32 |
|
| 2006 |
Chen X, Anderson J, Drobyski WR. Inhibition of T Cell Alloreactivity by Gr-1+Mac-1+ Myeloid Suppressor Cells. Blood. 108: 5177-5177. DOI: 10.1182/blood.V108.11.5177.5177 |
0.489 |
|
| 2006 |
Filicko J, Grosso D, Flomenberg P, Brunner J, Dessain S, Drobyski W, Ferber A, Friedman T, Kahkniashvili I, Keever-Taylor C, Mookerjee B, Wagner J, Korngold R, Flomenberg N. Accelerated immune recovery following LLME treated donor lymphocyte infusion Biology of Blood and Marrow Transplantation. 12: 77-78. DOI: 10.1016/J.Bbmt.2005.11.243 |
0.391 |
|
| 2005 |
Tivol E, Komorowski R, Drobyski WR. Emergent autoimmunity in graft-versus-host disease. Blood. 105: 4885-91. PMID 15746077 DOI: 10.1182/blood-2004-12-4980 |
0.514 |
|
| 2005 |
Gendelman M, Halligan N, Komorowski R, Logan B, Murphy WJ, Blazar BR, Pritchard KA, Drobyski WR. Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration. Blood. 105: 428-31. PMID 15331451 DOI: 10.1182/Blood-2004-01-0371 |
0.403 |
|
| 2004 |
Hari P, Logan B, Drobyski WR. Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity? Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 10: 743-7. PMID 15505605 DOI: 10.1016/J.Bbmt.2004.07.006 |
0.441 |
|
| 2004 |
Drobyski WR. The role of allogeneic transplantation in high-risk acute myelogenous leukemia. Leukemia. 18: 1565-8. PMID 15452588 DOI: 10.1038/sj.leu.2403482 |
0.338 |
|
| 2004 |
Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 172: 3328-36. PMID 14978141 DOI: 10.4049/Jimmunol.172.5.3328 |
0.558 |
|
| 2004 |
Hari P, Drobyski W. Temporally discordant graft versus leukemia (GVL) and graft versus host (GVH) responses after donor lymphocyte infusion therapy for relapsed chronic myelogenous leukemia Biology of Blood and Marrow Transplantation. 10: 55. DOI: 10.1016/j.bbmt.2003.12.279 |
0.316 |
|
| 2004 |
Woodliff J, Taylor C, Douek D, Margolis D, Drobyski W, Johnson B, Truitt R. Early production of donor-derived CD4+ CD25+ regulatory T cells in patients given hematopoietic stem cell transplants Biology of Blood and Marrow Transplantation. 10: 25. DOI: 10.1016/J.Bbmt.2003.12.102 |
0.587 |
|
| 2004 |
Filicko J, Grosso D, Flomenberg P, Friedman T, Brunner J, Dessain S, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Wagner J, Williams A, Korngold R, Flomenberg N. Accelerated immune reconstitution using LLME treated donor lymphocyte infusions Biology of Blood and Marrow Transplantation. 10: 22-23. DOI: 10.1016/J.Bbmt.2003.12.091 |
0.402 |
|
| 2003 |
Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, Drobyski WR. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 9: 742-52. PMID 14677113 DOI: 10.1016/j.bbmt.2003.09.007 |
0.533 |
|
| 2003 |
Burt RK, Drobyski WR, Seregina T, Traynor A, Oyama Y, Keever-Taylor C, Stefka J, Kuzel TM, Brush M, Rodriquez J, Burns W, Tennant L, Link C. Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions. Experimental Hematology. 31: 903-10. PMID 14550806 DOI: 10.1016/S0301-472X(03)00226-1 |
0.408 |
|
| 2003 |
Rosenblum MD, Drobyski WR, Keever-Taylor C, Chang CC. Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: Implications for minimal residual disease detection post-transplant Bone Marrow Transplantation. 31: 947-949. PMID 12748676 DOI: 10.1038/Sj.Bmt.1704039 |
0.417 |
|
| 2003 |
Drobyski WR, Gendelman M, Vodanovic-Jankovic S, Gorski J. Elimination of leukemia in the absence of lethal graft-versus-host disease after allogenic bone marrow transplantation. Journal of Immunology (Baltimore, Md. : 1950). 170: 3046-53. PMID 12626559 |
0.498 |
|
| 2002 |
Drobyski WR, Gendelman M. Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene. Leukemia & Lymphoma. 43: 2011-6. PMID 12481900 DOI: 10.1080/1042819021000016041 |
0.364 |
|
| 2002 |
Drobyski WR, Komorowski R, Logan B, Gendelman M. Role of the passive apoptotic pathway in graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 169: 1626-33. PMID 12133993 DOI: 10.4049/Jimmunol.169.3.1626 |
0.539 |
|
| 2002 |
Drobyski WR, Klein J, Flomenberg N, Pietryga D, Vesole DH, Margolis DA, Keever-Taylor CA. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood. 99: 806-14. PMID 11806980 DOI: 10.1182/Blood.V99.3.806 |
0.348 |
|
| 2002 |
Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins RH. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 405-12. PMID 11786567 DOI: 10.1200/JCO.20.2.405 |
0.341 |
|
| 2001 |
Drobyski WR, Morse HC, Burns WH, Casper JT, Sandford G. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene. Blood. 97: 2506-13. PMID 11290616 DOI: 10.1182/blood.V97.8.2506 |
0.514 |
|
| 2000 |
Salama M, Nevill T, Marcellus D, Parker P, Johnson M, Kirk A, Porter D, Giralt S, Levine JE, Drobyski W, Barrett AJ, Horowitz M, Collins RH. Donor leukocyte infusions for multiple myeloma Bone Marrow Transplantation. 26: 1179-1184. PMID 11149728 DOI: 10.1038/Sj.Bmt.1702685 |
0.318 |
|
| 2000 |
Collins RH, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W, Barrett J, Johnson M, Kirk A, Horowitz M, Parker P. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplantation. 26: 511-516. PMID 11019840 DOI: 10.1038/Sj.Bmt.1702555 |
0.364 |
|
| 2000 |
Drobyski WR, Vodanovic-Jankovic S, Klein J. Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice. Journal of Immunology (Baltimore, Md. : 1950). 165: 1634-40. PMID 10903774 DOI: 10.4049/Jimmunol.165.3.1634 |
0.409 |
|
| 2000 |
Drobyski WR. Evolving strategies to address adverse transplant outcomes associated with T cell depletion. Journal of Hematotherapy & Stem Cell Research. 9: 327-37. PMID 10894354 DOI: 10.1089/15258160050079434 |
0.456 |
|
| 2000 |
Drobyski WR. Adoptive immunotherapy using donor leukocyte infusions to treat relapsed hematologic malignancies after allogeneic bone marrow transplantation. Cancer Treatment and Research. 101: 233-66. PMID 10800652 DOI: 10.1007/978-1-4615-4987-1_11 |
0.313 |
|
| 1999 |
Drobyski WR, Majewski D, Hanson G. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 5: 222-30. PMID 10465102 DOI: 10.1053/bbmt.1999.v5.pm10465102 |
0.5 |
|
| 1999 |
Drobyski WR, Hessner MJ. The use of the polymerase chain reaction to predict for subsequent relapse in unrelated marrow transplantation for chronic myelogenous leukemia. Leukemia & Lymphoma. 31: 317-23. PMID 9869195 DOI: 10.3109/10428199809059224 |
0.371 |
|
| 1999 |
Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Keever-Taylor CA. T-Cell Depletion Plus Salvage Immunotherapy With Donor Leukocyte Infusions as a Strategy to Treat Chronic-Phase Chronic Myelogenous Leukemia Patients Undergoing HLA-Identical Sibling Marrow Transplantation Blood. 94: 434-441. DOI: 10.1182/Blood.V94.2.434 |
0.41 |
|
| 1999 |
Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Keever-Taylor CA. T-Cell Depletion Plus Salvage Immunotherapy With Donor Leukocyte Infusions as a Strategy to Treat Chronic-Phase Chronic Myelogenous Leukemia Patients Undergoing HLA-Identical Sibling Marrow Transplantation Blood. 94: 434-441. DOI: 10.1182/blood.V94.2.434 |
0.41 |
|
| 1998 |
Drobyski WR, Pelz C, Kabler-Babbitt C, Hessner M, Baxter-Lowe LA, Keever-Taylor CA. Successful unrelated marrow transplantation for patients over the age of 40 with chronic myelogenous leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 4: 3-12. PMID 9701386 DOI: 10.1053/bbmt.1998.v4.pm9701386 |
0.435 |
|
| 1998 |
Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski W, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. Bone Marrow Transplantation. 21: 893-899. PMID 9613781 DOI: 10.1038/Sj.Bmt.1701209 |
0.476 |
|
| 1997 |
Lawton CA, Cohen EP, Murray KJ, Derus SW, Casper JT, Drobyski WR, Horowitz MM, Moulder JE. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplantation. 20: 1069-74. PMID 9466280 DOI: 10.1038/Sj.Bmt.1701022 |
0.334 |
|
| 1997 |
Drobyski WR, Endean DJ, Klein JP, Hessner MJ. Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia. British Journal of Haematology. 98: 458-66. PMID 9266951 DOI: 10.1046/J.1365-2141.1997.2223039.X |
0.367 |
|
| 1997 |
Kawanishi Y, Passweg J, Drobyski W, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor C. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation Bone Marrow Transplantation. 19: 1069-1077. PMID 9193748 DOI: 10.1038/Sj.Bmt.1700807 |
0.582 |
|
| 1997 |
Drobyski WR, Majewski D. Donor γδ T Lymphocytes Promote Allogeneic Engraftment Across the Major Histocompatibility Barrier in Mice Blood. 89: 1100-1109. DOI: 10.1182/blood.v89.3.1100 |
0.496 |
|
| 1996 |
Drobyski W, Ul-Haq R, Majewski D, Chitambar C. Modulation of in vitro and in vivo T-cell responses by transferrin- gallium and gallium nitrate Blood. 88: 3056-3064. DOI: 10.1182/Blood.V88.8.3056.Bloodjournal8883056 |
0.572 |
|
| 1996 |
Drobyski W, Majewski D. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts Blood. 87: 5355-5369. DOI: 10.1182/Blood.V87.12.5355.Bloodjournal87125355 |
0.597 |
|
| 1995 |
Hessner M, Endean D, Casper J, Horowitz M, Keever-Taylor C, Roth M, Flomenberg N, Drobyski W. Use of unrelated marrow grafts compensates for reduced graft-versus- leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia Blood. 86: 3987-3996. DOI: 10.1182/Blood.V86.10.3987.Bloodjournal86103987 |
0.505 |
|
| 1994 |
Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, McAuliffe T, Camitta B, Horowitz MM, Bunin N. Increasing incidence of adenovirus disease in bone marrow transplant recipients. The Journal of Infectious Diseases. 169: 775-81. PMID 8133091 DOI: 10.1093/Infdis/169.4.775 |
0.312 |
|
| 1994 |
Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW. Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation. Blood. 84: 2363-73. PMID 7522627 DOI: 10.1182/Blood.V84.7.2363.2363 |
0.472 |
|
| 1994 |
Drobyski W, Ash R, Casper J, McAuliffe T, Horowitz M, Lawton C, Keever C, Baxter-Lowe L, Camitta B, Garbrecht F. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia Blood. 83: 1980-1987. DOI: 10.1182/Blood.V83.7.1980.1980 |
0.515 |
|
| 1993 |
Drobyski W, Keever C, Roth M, Koethe S, Hanson G, McFadden P, Gottschall J, Ash R, van Tuinen P, Horowitz M. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose Blood. 82: 2310-2318. DOI: 10.1182/Blood.V82.8.2310.Bloodjournal8282310 |
0.481 |
|
| 1993 |
Drobyski W, Keever C, Roth M, Koethe S, Hanson G, McFadden P, Gottschall J, Ash R, van Tuinen P, Horowitz M. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose Blood. 82: 2310-2318. DOI: 10.1182/blood.v82.8.2310.2310 |
0.386 |
|
| 1993 |
Drobyski W, Baxter-Lowe L, Truitt R. Detection of residual leukemia by the polymerase chain reaction and sequence-specific oligonucleotide probe hybridization after allogeneic bone marrow transplantation for AKR leukemia: a murine model for minimal residual disease Blood. 81: 551-559. DOI: 10.1182/Blood.V81.2.551.Bloodjournal812551 |
0.451 |
|
| 1990 |
Drobyski WR, Piaskowski V, Ash RC, Casper JT, Truitt RL. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. Transplantation. 50: 625-32. PMID 1699309 DOI: 10.1097/00007890-199010000-00020 |
0.556 |
|
| 1989 |
Drobyski W, Thibodeau S, Truitt R, Baxter-Lowe L, Gorski J, Jenkins R, Gottschall J, Ash R. Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism Blood. 74: 2285-2294. DOI: 10.1182/Blood.V74.6.2285.Bloodjournal7462285 |
0.541 |
|
| Show low-probability matches. |